Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada.
Division of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
J Am Coll Cardiol. 2018 Dec 4;72(22):2761-2777. doi: 10.1016/j.jacc.2018.08.2200.
The ideal aortic valve substitute for young and middle-aged adults remains elusive. The Ross procedure (pulmonary autograft replacement) is the only operation that allows replacement of the diseased aortic valve with a living substitute. However, use of this procedure has declined significantly due to concerns over increased surgical risk and potential long-term failure of the operation. Several recent publications from expert centers have shown that in the current era, the Ross procedure can be performed safely and reproducibly in appropriately selected patients. Furthermore, an increasing body of evidence suggests that the Ross procedure is associated with better long-term outcomes compared with conventional aortic valve replacement in young and middle-aged adults. In this paper, the authors review the indications and technical considerations of the Ross procedure, describe its advantages and drawbacks, and discuss patient selection criteria. Finally, the authors provide a comprehensive synthesis of the current Ross published reports to enable cardiologists and surgeons to make appropriate decisions for their patients with aortic valve disease.
对于中青年人群,理想的主动脉瓣置换仍然难以实现。Ross 手术(肺动脉自体移植置换)是唯一一种可将病变主动脉瓣置换为活体替代品的手术。然而,由于对手术风险增加和潜在长期手术失败的担忧,该手术的应用显著减少。来自专家中心的几项近期出版物表明,在当前时代,Ross 手术可在适当选择的患者中安全且可重复地进行。此外,越来越多的证据表明,与中青年人群的传统主动脉瓣置换相比,Ross 手术与更好的长期预后相关。本文作者回顾了 Ross 手术的适应证和技术要点,描述了其优缺点,并讨论了患者选择标准。最后,作者对当前 Ross 手术的报告进行了全面综合,使心脏病专家和外科医生能够为患有主动脉瓣疾病的患者做出适当的决策。